Berkshire Hathaway sold an additional 750,000 shares of DaVita Inc. between February 14 and February 19, according to a regulatory filing. These sales totaled approximately $115 million.
This transaction further reduced Berkshire's ownership stake in the kidney dialysis services provider by about 2%. Following this sale, Berkshire Hathaway now holds approximately 35.14 million shares of DaVita.
The continued divestment by Warren Buffett's conglomerate, which now holds about 44% of DaVita's outstanding shares, signals an ongoing rebalancing of its portfolio. This trend can be a point of concern for investors monitoring major institutional holdings.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.